The Scientific Advisory Board (SAB) provides independent expert guidance, ensure scientific quality, and offers external perspectives. The SAB comprises external experts (e.g. organ-on-chip, microfluidics, drug discovery), clinicians, industry stakeholders, patient group representatives, regulatory body representatives, policymakers, and funders.
- Alison Giles, Chief Executive, (chair of advisory board)
- Pelin Candarlioglu, Director,
- Vanessa Hebditch,
- Anthony Holmes, Director of Science and Technology,
- Roger Kamm,
- Joanne Larner, Associate Director and Head of In Vitro Toxicology,
- Tamir Rashid,
- Zahra Rattray,
- Dominic Williams, Senior Director, Non-Clinical Hepatic Safety,